HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaji, R. Articles by Sumner, A. J. Search for Related Content PubMed PubMed Citation Articles by Kaji, R. Articles by Sumner, A. J.

Ouabain reverses conduction disturbances in single demyelinated nerve fibers

Department of Neurology, Louisiana State University Medical Center, New Orleans, LA.

Symptoms in patients with demyelinating disorders are associated with 3 important conduction abnormalities: complete conduction block, rate-dependent conduction block, and slowed impulse conduction. The recent observation that the electrogenic Na/K pump causes the nerve membrane hyperpolarization responsible for rate-dependent conduction block in demyelinated axons raises the possibility that focal inhibition of the pump may reverse the rate-dependent block. Since the pump is also responsible for maintaining part of the resting membrane potential, pump inhibition might have an additional effect of reversing the complete conduction block by reducing the threshold. We have demonstrated that inhibition of the pump by topical application of ouabain, a short-acting cardiac glycoside, reverses the conduction abnormalities in acutely demyelinated single rat ventral root axons by reducing the threshold of transmission. Ouabain or other cardiac glycosides show potential promise as agents for trial in the symptomatic treatment of patients with MS and other demyelinating disorders.

Address correspondence and reprint requests to Dr. Kaji, Department of Neurology, Faculty of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyoku, Kyoto 606, Japan.

Supported by a grant from the National Multiple Sclerosis Society (RG-2099-A-1).

Presented in part at the fortieth annual meeting of the American Academy of Neurology, Cincinnati, OH, April 1988.

Received January 13, 1989. Accepted for publication in final form April 17, 1989.

This article has been cited by other articles:

				M. Moldovan, S. Alvarez, and C. Krarup Motor axon excitability during Wallerian degeneration Brain, February 1, 2009; 132(2): 511 - 523. [Abstract] [Full Text] [PDF]

				C. S.-Y. Lin, A. V. Krishnan, M.-J. Lee, A. S. Zagami, H.-L. You, C.-C. Yang, H. Bostock, and M. C. Kiernan Nerve function and dysfunction in acute intermittent porphyria Brain, September 1, 2008; 131(9): 2510 - 2519. [Abstract] [Full Text] [PDF]

				S. Vucic, A. V Krishnan, and M. C Kiernan Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1202 - 1208. [Abstract] [Full Text] [PDF]

				A. V. Krishnan, R. K. S. Phoon, B. A. Pussell, J. A. Charlesworth, H. Bostock, and M. C. Kiernan Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease Brain, June 1, 2006; 129(6): 1585 - 1592. [Abstract] [Full Text] [PDF]

				C. Cappelen-Smith, C. S.-Y. Lin, S. Kuwabara, and D. Burke Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy Brain, August 1, 2002; 125(8): 1850 - 1858. [Abstract] [Full Text] [PDF]

				R. Kaji, H. Bostock, N. Kohara, N. Murase, J. Kimura, and H. Shibasaki Activity-dependent conduction block in multifocal motor neuropathy Brain, August 1, 2000; 123(8): 1602 - 1611. [Abstract] [Full Text] [PDF]